ISMP’s subsidiary, Med Safety Board, has issued a call to action for manufacturers to ensure injectable medication labels are well-differentiated to prevent patient harm. The white paper includes a list of labeling attributes healthcare organizations should consider when purchasing or adding products to their formulary: www.ismp.org/ext/1418